title: Brightening up: the effect of the Physician Payment Sunshine Act on existing regulation of pharmaceutical marketing.
abstract: With the passage of the Physician Payment Sunshine Act as part of the federal health care reform law, pharmaceutical manufacturers are now required to disclose a wide range of payments made by manufacturers to physicians. We review current state regulation of pharmaceutical marketing and consider how the federal sunshine provision will affect existing marketing regulation. We analyze the legal and practical implications of the Physician Payment Sunshine Act.
authors.affiliation: Harvard University.
authors.forename: Igor
authors.initials: I
authors.lastname: Gorlach
authors.forename: Genevieve
authors.initials: G
authors.lastname: Pham-Kanter
mesh_terms: D016265:Conflict of Interest / Q000191:economics / Q000331:legislation & jurisprudence*; D030881:Disclosure / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D037921:Gift Giving; D006801:Humans; D040541:Marketing / Q000191:economics / Q000331:legislation & jurisprudence*; D010820:Physicians / Q000191:economics / Q000331:legislation & jurisprudence*; D011640:Public Policy / Q000331:legislation & jurisprudence; D014481:United States